Cycle Pharmaceuticals Acquires Applied Therapeutics at a Low Share Price

Applied Therapeutics shares are trading lower after Cycle Pharmaceuticals announced a definitive agreement to acquire the company at a low per share price of $0.088, reflecting investor concerns over valuation.